Disruption of the CED-9.CED-4 complex by EGL-1 is a critical step for programmed cell death in Caenorhabditis elegans

L del Peso1, V M Gonzalez, N Inohara

  • 1Department of Pathology and Comprehensive Cancer Center and the The University of Michigan, Ann Arbor, Michigan 48109, USA.

Insights

A mutation in the C. elegans CED-9 protein (CED-9G169E) blocks programmed cell death by preventing CED-4 release from the CED-9.CED-4 complex. This disruption inhibits apoptosis, highlighting CED-4 release as a crucial step.

Area of Science:

  • Cell biology
  • Genetics
  • Developmental biology

Background:

  • Programmed cell death (apoptosis) in C. elegans involves CED-3, CED-4, CED-9, and EGL-1.
  • A specific mutation, ced-9(n1950), results in a CED-9G169E protein that inhibits somatic cell death.

Purpose of the Study:

  • To investigate the molecular mechanism by which the CED-9G169E mutation prevents programmed cell death.
  • To elucidate the role of CED-4 release from the CED-9.CED-4 complex in apoptosis.

Main Methods:

  • Biochemical analyses of CED-9G169E protein interactions.
  • Co-localization studies in mammalian cells.
  • Assessment of apoptosis promotion by EGL-1 in the presence of wild-type vs. mutant CED-9.

Main Results:

  • CED-9G169E binds EGL-1 and CED-4, but with reduced affinity for EGL-1.
  • EGL-1 cannot disrupt the CED-9G169E.CED-4 interaction.
  • CED-4, CED-9G169E, and EGL-1 co-localize to mitochondria; EGL-1 does not induce CED-4 translocation to the cytosol.
  • EGL-1's ability to promote apoptosis is impaired when CED-9 is replaced by CED-9G169E.

Conclusions:

  • The release of CED-4 from the CED-9.CED-4 complex is essential for initiating programmed cell death in C. elegans.
  • The CED-9G169E mutation likely inhibits apoptosis by locking CED-4 within the CED-9.CED-4 complex, preventing its activation of downstream effectors.